Integra LifeSciences: opening of its first office in Shanghai, China

20 December 2011

Integra LifeSciences Holdings Corporation announced, on 5th December 2011, the opening of its first Asia business office in Shanghai, China, part of an on going expansion to serve one of the world's fastest developing medical device markets.

Stuart Essig, Integra's Chief Executive Officer, officiated at the opening ceremony of the office, which is located at the People's Square area of Huangpu District. Dignitaries from the Shanghai Food and Drug Administration (SFDA), relevant governmental departments, Integra employees, and members of the local media attended the event.

Statements of Stuart Essig, Integra's Chief Executive Officer and Alan Eng, Integra's Greater China General Manager

"I am delighted that Integra has opened an office in China," said Mr Essig.  "China's rapidly growing economy has created a significant medical device market that presents Integra with major growth opportunities. This is an important milestone for our company and a clear indication of the importance we place in the area."

Alan Eng will manage the new office as Integra's Greater China General Manager. Mr Eng has over 20 years of China multinational healthcare company experience. "I am extremely honored to lead Integra's first office in Asia," said Mr Eng. "With an initial staff of five, we aim to establish a stronger distribution network to greatly enhance our services to our customers in China, Hong Kong and Taiwan."

One of Integra's strengths is its diverse product categories

Integra is a leader in neurosurgery, offering a broad portfolio of:

  • implants,
  • devices,
  • instruments and
  • systems

used in neurosurgery, neuromonitoring, neurotrauma, and related critical care.

Its orthopedic products include devices and implants for: 

  • foot and ankle,
  • hand and wrist,
  • shoulder and elbow,
  • tendon and peripheral nerve protection and repair,
  • wound repair, and
  • spine.

In the United States, Integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices.

It distinguishes itself by emphasizing the importance of the field of regenerative medicine - which it defines as surgical implants derived from its proprietary collagen matrix technology.

"Having a direct presence in China enhances our local capability, supports our commitment to this important region, and allows us to offer innovative healthcare solutions for a vast patient population," said Joanne Harla, Integra's Vice President for Latin America, Asia Pacific and Canada. "Initially, we will focus on our neurosurgical business, but our future plans include product introductions in spine and orthobiologics, and an expansion of our existing orthopedics business."

Find out more

Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedics, neurosurgery, spine, reconstructive, and general surgery.

The Europe, Middle East and Africa headquarters of Integra LifeSciences is located in Lyon (Saint-Priest, France)